United Pharma Technologies (UPT) is a global life-science services company delivering CQV, validation, quality, automation, and regulatory compliance solutions to the pharmaceutical, biotechnology, medical device, and diagnostics sectors. With more than 1,500+ combined years of technical and regulatory experience, we help organizations achieve GMP-ready operations, audit preparedness, and commercial manufacturing excellence across highly regulated environments. With operations across Ireland, the USA, India, Canada, and Mexico, we offer a truly global execution model with scalable talent, standardized processes, and consistent, high-quality project delivery.

Our multidisciplinary team includes experts in CQV, process validation, biomedical and chemical engineering, QC microbiology, analytical sciences, QMS, clinical operations, pharmacovigilance, data integrity, industrial automation, and digital systems. We operate under global frameworks including FDA, EMA, EU-GMP, ICH, WHO, ISO, GAMP5, and 21 CFR Part 11, supporting end-to-end compliance from development.

UPT’s delivery model aligns with modern regulatory expectations - structured planning, risk-based validation, traceable decision-making, documented workflows, data-integrity controls, and lifecycle-based quality systems. Every project is managed with clarity, accountability, and transparent communication, ensuring clients have full visibility into progress, risks, and deliverables. We also embrace the technologies transforming next-gen manufacturing. Our teams support digital-twin environments, MES/LIMS integration, AI-enabled decision tools, continuous monitoring, and compliant automation (PLC/DCS/SCADA) to help clients advance digital maturity while maintaining regulatory robustness. We partners across biologics, vaccines, biosimilars, sterile injectables, and cell & gene therapy, where aseptic control, qualification depth, contamination control, and quality-by-design principles are critical to success.